· Venture Capital · 7 sources · Verified
September 9–18 Funding Backfill: Hackuity, Penelope Health, TUSK IC, Zero and HelmGuard
A targeted VCT backfill for September 9–18, covering cybersecurity, healthcare policy intelligence, satellite semiconductors and AI-native GTM software.
Editorial team
TL;DR: This backfill closes several material September 9–18 gaps that were not in the earlier publishing run.
Deal details & investors
Funding event
Ryft
Led by Gresham House Ventures
| Company | Financing | Focus |
|---|---|---|
| Penelope Health | $100M funding commitment | Healthcare policy intelligence |
| Hackuity | $19M Series B | Vulnerability operations |
| Ryft | £20M Series B | Payments infrastructure |
| TUSK IC | €15M Series A | Satellite communication semiconductors |
| Zero | $10.3M seed | AI-native GTM / post-CRM workflows |
| HelmGuard | $7.3M seed | Agentic GRC and security |
| Arcos | €5.5M seed | Civil-safety infrastructure |
Why these were worth adding
They fill useful entity gaps rather than simply increasing article count.
Penelope Health and Hackuity have measurable search demand with very low SEO difficulty. HelmGuard expands VCT's growing AI-agent security graph. TUSK IC adds semiconductor and space infrastructure coverage. Zero represents the rapidly growing "CRM replacement with agents" thesis. Ryft adds a meaningful UK payments Series B, while Arcos adds physical and critical-infrastructure security.
Source corrections
The strongest reason to backfill from primary sources is that several secondary summaries changed the numbers.
Penelope's own announcement says $100M committed funding, not €87M.
Hackuity says $19M, not €16M.
Those corrections are now reflected in the canonical event records.
Follow Venture Capital Tracker on Google
Add VCT as a preferred source to see more of our venture-capital reporting in Google Search.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
